⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - SPRY
prnewswire.com
SPRY
Kaplan Fox Notifies ARS Pharmaceuticals Inc. (SPRY) Investors of a Securities Class Action Lawsuit - Deadline is October 5, 2026 Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 - ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of ARS Pharmaceuticals Inc. to Contact the Firm Today!
accessnewswire.com
SPRY
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
SPRY
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
SPRY
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026
accessnewswire.com
SPRY
SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class Action - Contact SueWallSt
prnewswire.com
SPRY
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY) - Levi & Korsinsky Represents Shareholders
accessnewswire.com
SPRY
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
SPRY